$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Sugar modified oligonucleotides 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • C07H-021/04
  • C12Q-001/68
출원번호 US-0135202 (1998-08-17)
발명자 / 주소
  • Phillip Dan Cook
출원인 / 주소
  • ISIS Pharmaceuticals, Inc.
대리인 / 주소
    Woodcock Washburn LLP
인용정보 피인용 횟수 : 60  인용 특허 : 19

초록

Compositions and methods are provided for the treatment and diagnosis of diseases amenable to modulation of the production of selected proteins. In accordance with preferred embodiments, oligonucleotides and oligonucleotide analogs are provided which are specifically hybridizable with a selected seq

대표청구항

1. A compound having formula: [EQU1]wherein:T1 is a H, nucleoside, a nucleotide, or an oligonucleotide; T2 is H, a nucleoside, a nucleotide, or an oligonucleotide; B is a base; and X, Y, m, and n are selected such that either: X is H, Y is alkoxy, m≥2, and (m+n)≥3; or X is alkoxy, Y is H, n≥2, and (

이 특허에 인용된 특허 (19)

  1. Cook Phillip Dan ; Kawasaki Andrew Mamoru, 2'-O-modified oligonucleotides.
  2. Buhr Chris A. (Daly City CA) Matteucci Mark (Burlingame CA), 2\modified nucleoside and nucleotide compounds.
  3. Sproat Brian (Heidelberg DEX) Lamond Angus (Wiesenbach DEX), 2′-O-alkylnucleotides as well as polymers which contain such nucleotides.
  4. Cook Philip D. (Carlsbad CA) Sanghvi Yogesh S. (San Marcos CA), 4′-desmethyl nucleoside analog compounds.
  5. McCormick Randy M. (Wilmington DE), Arabinonucleic acid probes for DNA/RNA assays.
  6. Cook Philip D. (Carlsbad CA) Sanghvi Yogesh S. (Carlsbad CA), Backbone modified oligonucleotide analogs.
  7. Arnold ; Jr. Lyle J. ; Reynolds Mark A. ; Giachetti Cristina ; Lebedev Alexandre V., Chimeric oligonucleoside compounds.
  8. Ohtsuka Eiko (Sappro JPX) Inoue Hideo (Sappro JPX) Morisawa Hirokazu (Kawasaki JPX) Shibahara Susumu (Kawasaki JPX) Mukai Sachiko (Kawasaki JPX) Nishihara Tohru (Kurashiki JPX), Compounds for the cleavage at a specific position of RNA, oligomers employed for the formation of said compounds, and st.
  9. Metelev Valeri (Shrewsbury MA) Agrawal Sudhir (Shrewsbury MA), Hybrid oligonucleotide phosphorothioates.
  10. Rogers Thomas E. (Manchester MO) Gray Steven H. (Ellisville MO) Devadas Balekudru (Chesterfield MO) Adams Steven P. (St. Charles MO), Improved probes using nucleosides containing 3-dezauracil analogs.
  11. Kaji Akira (1-9 ; Daimoncho 1-chome Higashikurume-shi ; Tokyo JPX), Method for inhibiting propagation of virus and anti-viral agent.
  12. Walder Joseph A. (Iowa City IA) Walder Roxanne Y. (Iowa City IA) Eder Paul S. (Iowa City IA) Dagle John M. (Iowa City IA), Methods for blocking the expression of specifically targeted genes.
  13. Cook Phillip D. (Carlsbad CA), Monomers for preparation of oligonucleotides having chiral phosphorus linkages.
  14. Srivastava Suresh C. (Burlington MA) Roy Saroj K. (Waltham MA), N-protected-2′-O-methyl-ribonucleosides and N-protected 2′-O-methyl-3′-cyanoethyl-N-,N-diisopropyl phosphoramidite ri.
  15. Yamane Akio (Hiroshima JPX) Kawasoe Tatsuro (Hiroshima JPX) Tsukumo Noriko (Hiroshima JPX) Miyoshi Kenichi (Hiroshima JPX), Poly-labelled oligonucleotide derivative.
  16. Cook Philip D. (Carlsbad CA) Guinosso Charles J. (Carlsbad CA), Polyamine conjugated oligonucleotides.
  17. Rideout, Janet L.; Krenitsky, Thomas A., Process for producing deoxyribosides using bacterial phosphorylase.
  18. Miller Paul S. (Baltimore MD) Ts\O Paul O. P. (Lutherville MD), Process for selectively controlling unwanted expression or function of foreign nucleic acids in animal or mammalian cell.
  19. Inoue Hideo (Sapporo JPX) Ohtsuka Eiko (Sapporo JPX) Imura Akihiro (Tokyo JPX) Masuda Kenichi (Hachioji JPX) Kamimura Takashi (Tokyo JPX), Pyridopyrimidine nucleotide compounds.

이 특허를 인용한 특허 (60)

  1. Alexis, Frank; Iannacone, Matteo; Shi, Jinjun; Basto, Pamela; Moseman, Elliott Ashley; von Andrian, Ulrich; Langer, Robert S.; Farokhzad, Omid C.; Tonti, Elena, Adjuvant incorporation in immunoanotherapeutics.
  2. Alexis, Frank; Iannacone, Matteo; Shi, Jinjun; Basto, Pamela; Moseman, Elliott Ashley; von Andrian, Ulrich; Langer, Robert S.; Farokhzad, Omid C.; Tonti, Elena, Adjuvant incorporation in immunonanotherapeutics.
  3. Alexis, Frank; Iannacone, Matteo; Shi, Jinjun; Basto, Pamela; Moseman, Elliott Ashley; von Andrian, Ulrich; Langer, Robert S.; Farokhzad, Omid C.; Tonti, Elena, Adjuvant incorporation in immunonanotherapeutics.
  4. Alexis, Frank; Iannacone, Matteo; Shi, Jinjun; Basto, Pamela; Moseman, Elliott Ashley; von Andrian, Ulrich; Langer, Robert S.; Farokhzad, Omid C.; Tonti, Elena, Adjuvant incorporation in immunonanotherapeutics.
  5. Zhang, Liangfang; Radovic-Moreno, Aleksandar F.; Gu, Frank X.; Alexis, Frank; Langer, Robert S.; Farokhzad, Omid C., Amphiphilic compound assisted nanoparticles for targeted delivery.
  6. Bennett, C. Frank; Cowsert, Lex M.; Siwkowski, Andrew M., Antisense modulation of CD40 expression.
  7. Rossi, John J.; Bobbin, Maggie, Aptamer-mRNA conjugates for targeted protein or peptide expression and methods for their use.
  8. Rossi, John J.; Bobbin, Maggie, Aptamer-mRNA conjugates for targeted protein or peptide expression and methods for their use.
  9. Collins, James J.; Isaacs, Farren J.; Cantor, Charles R.; Dwyer, Daniel J., Cis/trans riboregulators.
  10. Collins, James J.; Isaacs, Farren J.; Cantor, Charles R.; Dwyer, Daniel J., Cis/trans riboregulators.
  11. Jon, Sangyong; Farokhazd, Omid C.; Langer, Robert S.; Cheng, Jianjun, Coated controlled release polymer particles as efficient oral delivery vehicles for biopharmaceuticals.
  12. Ilyinskii, Petr; Lipford, Grayson B.; Zepp, Charles, Dose selection of adjuvanted synthetic nanocarriers.
  13. Ilyinskii, Petr; Lipford, Grayson B.; Zepp, Charles, Dose selection of adjuvanted synthetic nanocarriers.
  14. Metelev,Valeri; Agrawal,Sudhir, Hybrid oligonucleotide phosphorothioates.
  15. Iannacone, Matteo; Alexis, Frank; Basto, Pamela; Moseman, Elliott Ashley; Shi, Jinjun; Langer, Robert S.; Farokhzad, Omid C.; von Andrian, Ulrich; Tonti, Elena, Immunonanotherapeutics that provide IGG humoral response without T-cell antigen.
  16. Iannacone, Matteo; Alexis, Frank; Basto, Pamela; Moseman, Elliott Ashley; Shi, Jinjun; Langer, Robert S.; Farokhzad, Omid C.; von Andrian, Ulrich; Tonti, Elena, Immunonanotherapeutics that provide IgG humoral response without T-cell antigen.
  17. Woolf, Tod M.; Kamens, Joanne; Khvorova, Anastasia; Salomon, William, Inhibition of MAP4K4 through RNAI.
  18. Kamens, Joanne; Khvorova, Anastasia, Inhibition of PCSK9 through RNAI.
  19. Kamens, Joanne; Khvorova, Anastasia, Inhibition of PCSK9 through RNAi.
  20. Zusman, Susan B.; Tworoger, Michael, Injecting drosophila embryos.
  21. Zusman, Susan B.; Tworoger, Michael, Injecting embryos.
  22. Karnik, Rohit; Gu, Frank X.; Basto, Pamela; Cannizzaro, Chris; Khademhosseini, Alireza; Langer, Robert S.; Farokhzad, Omid C., Microfluidic synthesis of organic nanoparticles.
  23. Pavco, Pamela A.; Kamens, Joanne; Woolf, Tod M.; Salomon, William; Khvorova, Anastasia, Modified RNAi polynucleotides and uses thereof.
  24. Bennett, C. Frank; Cowsert, Lex M.; Freier, Susan M., Modulation of CD40 expression.
  25. Bennett, C. Frank; Cowsert, Lex M.; Freier, Susan M., Modulation of CD40 expression.
  26. Khvorova, Anastasia; Salomon, William; Kamens, Joanne; Samarsky, Dmitry; Woolf, Tod M.; Miller, Michelle; Bulock, Karen G., Neutral nanotransporters.
  27. Iannacone, Matteo; von Andrian, Ulrich; Farokhzad, Omid C.; Alexis, Frank; Basto, Pamela; Shi, Jinjun; Moseman, Elliott Ashley; Langer, Robert S.; Tonti, Elena, Nicotine immunonanotherapeutics.
  28. von Andrian, Ulrich; Farokhzad, Omid C.; Alexis, Frank; Iannacone, Matteo; Basto, Pamela; Shi, Jinjun; Moseman, Elliott Ashley; Langer, Robert S.; Tonti, Elena, Nicotine immunonanotherapeutics.
  29. Moretti, Matteo G.; Freed, Lisa E.; Langer, Robert S., Oscillating cell culture bioreactor.
  30. Samarsky, Dmitry; Woolf, Tod M., Phagocytic cell delivery of RNAI.
  31. Radovic-Moreno, Aleksandar F.; Zhang, Liangfang; Langer, Robert S.; Farokhzad, Omid C., Polymer-encapsulated reverse micelles.
  32. Gu, Frank X.; Farokhzad, Omid C.; Langer, Robert S.; Teply, Benjamin A., Polymers for functional particles.
  33. Gu, Frank X.; Farokhzad, Omid C.; Langer, Robert S.; Teply, Benjamin A., Polymers for functional particles.
  34. Gu, Frank X.; Farokhzad, Omid C.; Langer, Robert S.; Teply, Benjamin A., Polymers for functional particles.
  35. Gu, Frank X.; Teply, Benjamin A.; Langer, Robert S.; Farokhzad, Omid C., Polymers for functional particles.
  36. Liu, David R.; Phillips, Kevin John; Lawrence, Michael S., Protein surface remodeling.
  37. Liu, David R.; Phillips, Kevin John; Lawrence, Michael S., Protein surface remodeling.
  38. Woolf, Tod M.; Kamens, Joanne; Salomon, William; Khvorova, Anastasia, RNA duplexes with single stranded phosphorothioate nucleotide regions for additional functionality.
  39. Khvorova, Anastasia; Salomon, William; Kamens, Joanne; Samarsky, Dmitry; Woolf, Tod M.; Pavco, Pamela A.; Libertine, Lyn; Cardia, James; Bulock, Karen G., RNA interference in dermal and fibrotic indications.
  40. Khvorova, Anastasia; Salomon, William; Kamens, Joanne; Samarsky, Dmitry; Woolf, Tod M.; Pavco, Pamela A.; Libertine, Lyn; Cardia, James; Bulock, Karen G., RNA interference in dermal and fibrotic indications.
  41. Libertine, Lyn; Khvorova, Anastasia; Salomon, William; Kamens, Joanne; Samarsky, Dmitry; Woolf, Tod M.; Cardia, James, RNA interference in ocular indications.
  42. Libertine, Lyn; Khvorova, Anastasia; Salomon, William; Kamens, Joanne; Samarsky, Dmitry; Woolf, Tod M.; Cardia, James; Pavco, Pamela A., RNA interference in ocular indications.
  43. Khvorova, Anastasia; Salomon, William; Kamens, Joanne; Samarsky, Dmitry; Woolf, Tod M.; Pavco, Pamela A.; Cardia, James, RNA interference in skin indications.
  44. Khvorova, Anastasia; Salomon, William; Kamens, Joanne; Samarsky, Dmitry; Woolf, Tod M.; Pavco, Pamela A.; Cardia, James, RNA interference in skin indications.
  45. Khvorova, Anastasia; Salomon, William; Kamens, Joanne; Samarsky, Dmitry; Woolf, Tod M.; Pavco, Pamela A.; Cardia, James, RNA interference in skin indications.
  46. Khvorova, Anastasia; Salomon, William; Kamens, Joanne; Samarsky, Dmitry; Woolf, Tod M.; Cardia, James, Reduced size self-delivering RNAi compounds.
  47. Khvorova, Anastasia; Salomon, William; Kamens, Joanne; Samarsky, Dmitry; Woolf, Tod M.; Cardia, James, Reduced size self-delivering RNAi compounds.
  48. Khvorova, Anastasia; Salomon, William; Kamens, Joanne; Samarsky, Dmitry; Woolf, Tod M.; Cardia, James, Reduced size self-delivering RNAi compounds.
  49. Khvorova, Anastasia; Salomon, William; Kamens, Joanne; Samarsky, Dmitry; Woolf, Tod M.; Cardia, James, Reduced size self-delivering RNAi compounds.
  50. Khvorova, Anastasia; Salomon, William; Kamens, Joanne; Samarsky, Dmitry; Woolf, Tod M.; Cardia, James, Reduced size self-delivering RNAi compounds.
  51. Liu, David R.; McNaughton, Brian R.; Cronican, James Joseph; Thompson, David B., Supercharged proteins for cell penetration.
  52. Farokhzad, Omid C.; Radovic-Moreno, Aleksandar Filip; Langer, Robert S., System for screening particles.
  53. Cheng, Jianjun; Farokhzad, Omid C.; Langer, Robert S.; Teply, Benjamin A.; Zale, Stephen E., System for targeted delivery of therapeutic agents.
  54. Farokhzad, Omid C.; Cheng, Jianjun; Teply, Benjamin A.; Langer, Robert S.; Zale, Stephen E., System for targeted delivery of therapeutic agents.
  55. Shi, Jinjun; Alexis, Frank; Iannacone, Matteo; Moseman, Elliott Ashley; Basto, Pamela; Langer, Robert S.; Farokhzad, Omid C.; von Andrian, Ulrich H.; Tonti, Elena, Targeting of antigen presenting cells with immunonanotherapeutics.
  56. Shi, Jinjun; Alexis, Frank; Iannacone, Matteo; Moseman, Elliott Ashley; Basto, Pamela; Langer, Robert S.; Farokhzad, Omid C.; von Andrian, Ulrich; Tonti, Elena, Targeting of antigen presenting cells with immunonanotherapeutics.
  57. Shi, Jinjun; Alexis, Frank; Iannacone, Matteo; Moseman, Elliott Ashley; Basto, Pamela; Langer, Robert S.; Farokhzad, Omid C.; von Andrian, Ulrich; Tonti, Elena, Targeting of antigen presenting cells with immunonanotherapeutics.
  58. von Andrian, Ulrich H.; Farokhzad, Omid C.; Langer, Robert S.; Junt, Tobias; Moseman, Elliott Ashley; Zhang, Liangfang; Basto, Pamela; Iannacone, Matteo; Alexis, Frank, Vaccine nanotechnology.
  59. von Andrian, Ulrich H.; Farokhzad, Omid C.; Langer, Robert S.; Junt, Tobias; Moseman, Elliott Ashley; Zhang, Liangfang; Basto, Pamela; Iannacone, Matteo; Alexis, Frank, Vaccine nanotechnology.
  60. von Andrian, Ulrich H.; Farokhzad, Omid C.; Langer, Robert S.; Junt, Tobias; Moseman, Elliott Ashley; Zhang, Liangfang; Basto, Pamela; Iannacone, Matteo; Alexis, Frank, Vaccine nanotechnology.
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로